Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
[HIV pre-exposure prophylaxis in women].

MMW Fortschritte der Medizin

Haberl A.
PMID: 28597264
MMW Fortschr Med. 2017 Jun;159:42-44. doi: 10.1007/s15006-017-9736-9.

No abstract available.

Cite
Haberl A. PrEP: Profitieren Frauen weniger? [HIV pre-exposure prophylaxis in women]. MMW Fortschr Med. 2017;159:42-44doi: 10.1007/s15006-017-9736-9.
Haberl, A. (2017). PrEP: Profitieren Frauen weniger? [HIV pre-exposure prophylaxis in women]. MMW Fortschritte der Medizin, 15942-44. https://doi.org/10.1007/s15006-017-9736-9
Haberl, Annette. "PrEP: Profitieren Frauen weniger?" [HIV pre-exposure prophylaxis in women]. MMW Fortschritte der Medizin vol. 159 (2017): 42-44. doi: https://doi.org/10.1007/s15006-017-9736-9
Haberl A. PrEP: Profitieren Frauen weniger? [HIV pre-exposure prophylaxis in women]. MMW Fortschr Med. 2017 Jun;159:42-44. doi: 10.1007/s15006-017-9736-9. German. PMID: 28597264.
Copy Download .nbib Format: NLM
Update on pre-exposure prophylaxis.

Journal watch. AIDS clinical care

Abdool Karim SS.
PMID: 27652425
J Watch AIDS Clin Care. 2011 May;23(5):37-8.

No abstract available.

Cite
Abdool Karim SS. Update on pre-exposure prophylaxis. J Watch AIDS Clin Care. 2011;23(5):37-8
Abdool Karim, S. S. (2011). Update on pre-exposure prophylaxis. Journal watch. AIDS clinical care, 23(5), 37-8.
Abdool Karim, Salim S. "Update on pre-exposure prophylaxis." Journal watch. AIDS clinical care vol. 23,5 (2011): 37-8.
Abdool Karim SS. Update on pre-exposure prophylaxis. J Watch AIDS Clin Care. 2011 May;23(5):37-8. PMID: 27652425.
Copy Download .nbib Format: NLM
Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter.

Health communication

McLaughlin ML, Hou J, Meng J, Hu CW, An Z, Park M, Nam Y.
PMID: 26756069
Health Commun. 2016 Aug;31(8):998-1007. doi: 10.1080/10410236.2015.1027033. Epub 2016 Jan 12.

Previous literature has suggested that examining Twitter messages can be productive for studying how the public shares and spreads health information on social media. Preexposure prophylaxis (PrEP) is a promising approach to HIV prevention, yet there are many issues...

Cite
McLaughlin ML, Hou J, Meng J, et al. Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter. Health Commun. 2016;31(8):998-1007doi: 10.1080/10410236.2015.1027033.
McLaughlin, M. L., Hou, J., Meng, J., Hu, C. W., An, Z., Park, M., & Nam, Y. (2016). Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter. Health communication, 31(8), 998-1007. https://doi.org/10.1080/10410236.2015.1027033
McLaughlin, Margaret L, et al. "Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter." Health communication vol. 31,8 (2016): 998-1007. doi: https://doi.org/10.1080/10410236.2015.1027033
McLaughlin ML, Hou J, Meng J, Hu CW, An Z, Park M, Nam Y. Propagation of Information About Preexposure Prophylaxis (PrEP) for HIV Prevention Through Twitter. Health Commun. 2016 Aug;31(8):998-1007. doi: 10.1080/10410236.2015.1027033. Epub 2016 Jan 12. PMID: 26756069.
Copy Download .nbib Format: NLM
Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea.

PloS one

Kim SB, Yoon M, Ku NS, Kim MH, Song JE, Ahn JY, Jeong SJ, Kim C, Kwon HD, Lee J, Smith DM, Choi JY.
PMID: 24662776
PLoS One. 2014 Mar 24;9(3):e90080. doi: 10.1371/journal.pone.0090080. eCollection 2014.

BACKGROUND: Multiple prevention measures have the possibility of impacting HIV incidence in South Korea, including early diagnosis, early treatment, and pre-exposure prophylaxis (PrEP). We investigated how each of these interventions could impact the local HIV epidemic, especially among men...

Cite
Kim SB, Yoon M, Ku NS, et al. Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea. PLoS One. 2014;9(3):e90080doi: 10.1371/journal.pone.0090080.
Kim, S. B., Yoon, M., Ku, N. S., Kim, M. H., Song, J. E., Ahn, J. Y., Jeong, S. J., Kim, C., Kwon, H. D., Lee, J., Smith, D. M., & Choi, J. Y. (2014). Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea. PloS one, 9(3), e90080. https://doi.org/10.1371/journal.pone.0090080
Kim, Sun Bean, et al. "Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea." PloS one vol. 9,3 (2014): e90080. doi: https://doi.org/10.1371/journal.pone.0090080
Kim SB, Yoon M, Ku NS, Kim MH, Song JE, Ahn JY, Jeong SJ, Kim C, Kwon HD, Lee J, Smith DM, Choi JY. Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea. PLoS One. 2014 Mar 24;9(3):e90080. doi: 10.1371/journal.pone.0090080. eCollection 2014. PMID: 24662776; PMCID: PMC3963840.
Copy Download .nbib Format: NLM
Use of meta-analysis in systematic review: when is too much?.

AIDS (London, England)

Davalos-Soria D, Mares-Chiyón A, Tejada RA.
PMID: 30829748
AIDS. 2019 Mar 15;33(4):764-765. doi: 10.1097/QAD.0000000000002106.

No abstract available.

Cite
Davalos-Soria D, Mares-Chiyón A, Tejada RA. Use of meta-analysis in systematic review: when is too much?. AIDS. 2019;33(4):764-765doi: 10.1097/QAD.0000000000002106.
Davalos-Soria, D., Mares-Chiyón, A., & Tejada, R. A. (2019). Use of meta-analysis in systematic review: when is too much?. AIDS (London, England), 33(4), 764-765. https://doi.org/10.1097/QAD.0000000000002106
Davalos-Soria, Diana, et al. "Use of meta-analysis in systematic review: when is too much?." AIDS (London, England) vol. 33,4 (2019): 764-765. doi: https://doi.org/10.1097/QAD.0000000000002106
Davalos-Soria D, Mares-Chiyón A, Tejada RA. Use of meta-analysis in systematic review: when is too much?. AIDS. 2019 Mar 15;33(4):764-765. doi: 10.1097/QAD.0000000000002106. PMID: 30829748.
Copy Download .nbib Format: NLM
Ending the HIV epidemic with the Help of biomedical Prevention Interventions.

MD advisor : a journal for New Jersey medical community

Toynton P, O'Brien KA.
PMID: 28586567
MD Advis. 2017;10(2):7-14.

No abstract available.

Cite
Toynton P, O'Brien KA. Ending the HIV epidemic with the Help of biomedical Prevention Interventions. MD Advis. 2017;10(2):7-14
Toynton, P., & O'Brien, K. A. (2017). Ending the HIV epidemic with the Help of biomedical Prevention Interventions. MD advisor : a journal for New Jersey medical community, 10(2), 7-14.
Toynton, Paula, and O'Brien, Kathy Ahearn. "Ending the HIV epidemic with the Help of biomedical Prevention Interventions." MD advisor : a journal for New Jersey medical community vol. 10,2 (2017): 7-14.
Toynton P, O'Brien KA. Ending the HIV epidemic with the Help of biomedical Prevention Interventions. MD Advis. 2017;10(2):7-14. PMID: 28586567.
Copy Download .nbib Format: NLM
HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action.

Current HIV/AIDS reports

Poteat T, Malik M, Scheim A, Elliott A.
PMID: 28752285
Curr HIV/AIDS Rep. 2017 Aug;14(4):141-152. doi: 10.1007/s11904-017-0360-1.

PURPOSE OF REVIEW: The purpose of this review is to summarize the available evidence-based HIV prevention interventions tailored for transgender people.RECENT FINDINGS: A limited number of evidence-based HIV prevention interventions have been tested with transgender populations. Most existing interventions...

Cite
Poteat T, Malik M, Scheim A, et al. HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action. Curr HIV/AIDS Rep. 2017;14(4):141-152doi: 10.1007/s11904-017-0360-1.
Poteat, T., Malik, M., Scheim, A., & Elliott, A. (2017). HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action. Current HIV/AIDS reports, 14(4), 141-152. https://doi.org/10.1007/s11904-017-0360-1
Poteat, Tonia, et al. "HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action." Current HIV/AIDS reports vol. 14,4 (2017): 141-152. doi: https://doi.org/10.1007/s11904-017-0360-1
Poteat T, Malik M, Scheim A, Elliott A. HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action. Curr HIV/AIDS Rep. 2017 Aug;14(4):141-152. doi: 10.1007/s11904-017-0360-1. PMID: 28752285; PMCID: PMC5896563.
Copy Download .nbib Format: NLM
Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know.

Dermatologic clinics

Katz KA, Park AJ, Marcus JL.
PMID: 32115133
Dermatol Clin. 2020 Apr;38(2):233-238. doi: 10.1016/j.det.2019.10.008. Epub 2019 Nov 23.

HIV remains an important public health concern in the United States, particularly for men who have sex with men (MSM) and transgender persons. With HIV preexposure prophylaxis (PrEP), persons who are HIV-uninfected take antiretroviral medications to prevent HIV infection....

Cite
Katz KA, Park AJ, Marcus JL. Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know. Dermatol Clin. 2019;38(2):233-238doi: 10.1016/j.det.2019.10.008.
Katz, K. A., Park, A. J., & Marcus, J. L. (2020). Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know. Dermatologic clinics, 38(2), 233-238. https://doi.org/10.1016/j.det.2019.10.008
Katz, Kenneth A, et al. "Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know." Dermatologic clinics vol. 38,2 (2020): 233-238. doi: https://doi.org/10.1016/j.det.2019.10.008
Katz KA, Park AJ, Marcus JL. Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:: What Dermatologists Need to Know. Dermatol Clin. 2020 Apr;38(2):233-238. doi: 10.1016/j.det.2019.10.008. Epub 2019 Nov 23. PMID: 32115133; PMCID: PMC7183314.
Copy Download .nbib Format: NLM
Ending the HIV Epidemic in the United States-The Roles of Increased Testing and Preexposure Prophylaxis.

JAMA internal medicine

Janssen JM, Katz MH.
PMID: 31738368
JAMA Intern Med. 2020 Jan 01;180(1):130. doi: 10.1001/jamainternmed.2019.5442.

No abstract available.

Cite
Janssen JM, Katz MH. Ending the HIV Epidemic in the United States-The Roles of Increased Testing and Preexposure Prophylaxis. JAMA Intern Med. 2020;180(1):130doi: 10.1001/jamainternmed.2019.5442.
Janssen, J. M., & Katz, M. H. (2020). Ending the HIV Epidemic in the United States-The Roles of Increased Testing and Preexposure Prophylaxis. JAMA internal medicine, 180(1), 130. https://doi.org/10.1001/jamainternmed.2019.5442
Janssen, Julia M, and Katz, Mitchell H. "Ending the HIV Epidemic in the United States-The Roles of Increased Testing and Preexposure Prophylaxis." JAMA internal medicine vol. 180,1 (2020): 130. doi: https://doi.org/10.1001/jamainternmed.2019.5442
Janssen JM, Katz MH. Ending the HIV Epidemic in the United States-The Roles of Increased Testing and Preexposure Prophylaxis. JAMA Intern Med. 2020 Jan 01;180(1):130. doi: 10.1001/jamainternmed.2019.5442. PMID: 31738368.
Copy Download .nbib Format: NLM
Is event-driven PrEP dosing for HIV as effective as daily dosing?.

The Journal of family practice

Olsen T, Lally-Montgomery Z, Kelsberg G, Safranek S, Neher J.
PMID: 34410919
J Fam Pract. 2021 Jun;70(5):253-255. doi: 10.12788/jfp.0207.

PROBABLY, although there are no head-to-head trials comparing the 2 dosing regimens. Event-driven pre-exposure prophylaxis (PrEP) dosing reduces HIV conversion by 86% compared to placebo (strength of recommendation [SOR]: B, large randomized controlled trial [RCT]). Daily PrEP reduces HIV...

Cite
Olsen T, Lally-Montgomery Z, Kelsberg G, et al. Is event-driven PrEP dosing for HIV as effective as daily dosing?. J Fam Pract. 2021;70(5):253-255doi: 10.12788/jfp.0207.
Olsen, T., Lally-Montgomery, Z., Kelsberg, G., Safranek, S., & Neher, J. (2021). Is event-driven PrEP dosing for HIV as effective as daily dosing?. The Journal of family practice, 70(5), 253-255. https://doi.org/10.12788/jfp.0207
Olsen, Tory, et al. "Is event-driven PrEP dosing for HIV as effective as daily dosing?." The Journal of family practice vol. 70,5 (2021): 253-255. doi: https://doi.org/10.12788/jfp.0207
Olsen T, Lally-Montgomery Z, Kelsberg G, Safranek S, Neher J. Is event-driven PrEP dosing for HIV as effective as daily dosing?. J Fam Pract. 2021 Jun;70(5):253-255. doi: 10.12788/jfp.0207. PMID: 34410919.
Copy Download .nbib Format: NLM
HIV Pre-exposure Prophylaxis Medication Sharing Among HIV-Negative Men Who Have Sex With Men.

JAMA network open

Mansergh G, Mayer K, Hirshfield S, Stephenson R, Sullivan P.
PMID: 32915232
JAMA Netw Open. 2020 Sep 01;3(9):e2016256. doi: 10.1001/jamanetworkopen.2020.16256.

No abstract available.

Cite
Mansergh G, Mayer K, Hirshfield S, et al. HIV Pre-exposure Prophylaxis Medication Sharing Among HIV-Negative Men Who Have Sex With Men. JAMA Netw Open. 2020;3(9):e2016256doi: 10.1001/jamanetworkopen.2020.16256.
Mansergh, G., Mayer, K., Hirshfield, S., Stephenson, R., & Sullivan, P. (2020). HIV Pre-exposure Prophylaxis Medication Sharing Among HIV-Negative Men Who Have Sex With Men. JAMA network open, 3(9), e2016256. https://doi.org/10.1001/jamanetworkopen.2020.16256
Mansergh, Gordon, et al. "HIV Pre-exposure Prophylaxis Medication Sharing Among HIV-Negative Men Who Have Sex With Men." JAMA network open vol. 3,9 (2020): e2016256. doi: https://doi.org/10.1001/jamanetworkopen.2020.16256
Mansergh G, Mayer K, Hirshfield S, Stephenson R, Sullivan P. HIV Pre-exposure Prophylaxis Medication Sharing Among HIV-Negative Men Who Have Sex With Men. JAMA Netw Open. 2020 Sep 01;3(9):e2016256. doi: 10.1001/jamanetworkopen.2020.16256. PMID: 32915232; PMCID: PMC7489847.
Copy Download .nbib Format: NLM
Preexposure Prophylaxis for HIV: An Emerging Preventive Strategy to End Ongoing Pandemic.

The Journal of the Association of Physicians of India

Kamble TK, Gadewar PM, Kansal S.
PMID: 27734641
J Assoc Physicians India. 2016 Apr;64(4):47-50.

HIV/AIDS continues to have an extraordinary public health impact. Although the HIV/AIDS epidemic on the whole is plateauing, it is spreading rapidly among certain populations. We enumerate here some HIV preventive modalities that have been demonstrated to be effective...

Cite
Kamble TK, Gadewar PM, Kansal S. Preexposure Prophylaxis for HIV: An Emerging Preventive Strategy to End Ongoing Pandemic. J Assoc Physicians India. 2016;64(4):47-50
Kamble, T. K., Gadewar, P. M., & Kansal, S. (2016). Preexposure Prophylaxis for HIV: An Emerging Preventive Strategy to End Ongoing Pandemic. The Journal of the Association of Physicians of India, 64(4), 47-50.
Kamble, T K, et al. "Preexposure Prophylaxis for HIV: An Emerging Preventive Strategy to End Ongoing Pandemic." The Journal of the Association of Physicians of India vol. 64,4 (2016): 47-50.
Kamble TK, Gadewar PM, Kansal S. Preexposure Prophylaxis for HIV: An Emerging Preventive Strategy to End Ongoing Pandemic. J Assoc Physicians India. 2016 Apr;64(4):47-50. PMID: 27734641.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries